Ticker Details
Codexis, Inc. Codexis Inc is a biotech company. It develops proprietary biocatalysts-enzymes or microbes that initiate or accelerate chemical reactions. It offers its products to the pharmaceutical industry. The company also develops advanced biofuels.
IPO Date:	April 22, 2010
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$218.09M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.22 | 2.83%
Avg Daily Range (30 D):	$0.08 | 5.33%
Avg Daily Range (90 D):	$0.06 | 3.88%

Institutional Daily Volume
Avg Daily Volume:	.37M
Avg Daily Volume (30 D):	2.97M
Avg Daily Volume (90 D):	1.67M

Trade Size
Avg Trade Size (Sh.):	120
Avg Trade Size (Sh.) (30 D):	223
Avg Trade Size (Sh.) (90 D):	217

Institutional Trades
Total Institutional Trades:	1,261
Avg Institutional Trade:	$1.45M
Avg Institutional Trade (30 D):	$.69M
Avg Institutional Trade (90 D):	$.93M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.28M
Avg Closing Trade (30 D):	$.69M
Avg Closing Trade (90 D):	$.63M
Avg Closing Volume:	93.82K

News

Aug 28, 2025 @ 1:00 PM Codexis to Participate in Cantor Global Healthcare... Source: Georgia Erbez

May 22, 2025 @ 11:00 AM Codexis’ Landmark Presentations at TIDES US... Source: N/A

Apr 9, 2025 @ 9:00 PM Codexis Announces Byron Dorgan to Retire from Boar... Source: N/A

Feb 20, 2025 @ 3:00 PM Specialty Enzymes Market to Expand at 7.5% CAGR, R... Source: Sns Insider

Dec 4, 2024 @ 6:00 PM Global Artificial Sweeteners Market to Observe Gro... Source: Delveinsight

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.5	$.12	$-.5
Diluted EPS	$-.5	$.12	$-.5
Revenue	$70.39M	$38.92M	$70.39M
Gross Profit	$61.05M	$36.87M	$61.05M
Net Income / Loss	$-43.97M	$9.6M	$-43.97M
Operating Income / Loss	$-41.74M	$10.56M	$-41.74M
Cost of Revenue	$9.34M	$2.04M	$9.34M
Net Cash Flow	$32.05M	$25.99M	$32.05M
PE Ratio